These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8938227)

  • 1. Synchronous bilateral primary male breast carcinoma with hyperprolactinemia.
    Karamanakos P; Apostolopoulos V; Fafouliotis S; Mela A; Ziounas Y; Trafalis DT
    Acta Oncol; 1996; 35(6):757-9. PubMed ID: 8938227
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperprolactinemia in craniopharyngiomas].
    Aksenova MA; Korshunov AG
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):26-9. PubMed ID: 2750397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Macroprolactinemia--a more common cause of hyperprolactinemia than generally believed].
    Sane T; Hekim C; Alfthan H; Stenman UH; Välimäki M
    Duodecim; 2002; 118(16):1671-5. PubMed ID: 12271945
    [No Abstract]   [Full Text] [Related]  

  • 4. Asymptomatic hyperprolactinemia resulting from macroprolactinemia.
    Corenblum B
    Fertil Steril; 1990 Jan; 53(1):165-7. PubMed ID: 2295337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin bioassay and hyperprolactinemia.
    Peabody CA; Schultz PN; Warner MD; Worsley IG; Friesen HG; Samaan NA
    J Endocrinol Invest; 1992; 15(7):497-9. PubMed ID: 1360020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperprolactinemia].
    Müller OA; von Werder K
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolactin response to clomiphene citrate is different in hyperprolactinemic polycystic ovary syndrome and idiopathic hyperprolactinemia.
    Lewinthal D; Corenblum B; Taylor PJ
    Int J Fertil; 1987; 32(3):185-7, 191. PubMed ID: 2885281
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis of hyperprolactinemia: determination of prolactin level at rest].
    Ishay A; Luboshitzky R
    Harefuah; 1998 Nov; 135(9):348-50, 408, 407. PubMed ID: 10911442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactinomas.
    Hortin GL
    N Engl J Med; 2004 Mar; 350(10):1054-7; author reply 1054-7. PubMed ID: 15002120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heterogeneity of immunoreactive prolactin in hyperprolactinemia of various origin].
    Bulatov AA; Makarovskaia EE; Dzeranova LK; Smirnova NB; Chernogolov VA; Marova EI; Mel'nichenko GA; Dedov II
    Probl Endokrinol (Mosk); 1992; 38(6):13-6. PubMed ID: 1302839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
    Patel DD; Bhatavdekar JM; Chikhlikar PR; Ghosh N; Suthar TP; Shah NG; Mehta RH; Balar DB
    J Surg Oncol; 1996 Jun; 62(2):86-92. PubMed ID: 8649046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect.
    Dagdelen S; Usman A
    Minerva Endocrinol; 2010 Jun; 35(2):53-9. PubMed ID: 20595935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous double primary malignancy: intracystic papillary carcinoma male breast and adenocarcinoma stomach.
    Killedar MM; Kulkarni SH; Agashe SR; Mane V
    J Indian Med Assoc; 2013 May; 111(5):350. PubMed ID: 24765702
    [No Abstract]   [Full Text] [Related]  

  • 14. [Features of pituitary tumors and incidentalomas in hyper- and hypoprolactinemia].
    Nag' IuG
    Vopr Onkol; 2008; 54(6):734-8. PubMed ID: 19241849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male.
    Forloni F; Giovilli M; Pecis C; Bortolani E; Preziosi A; Barzaghi ME; Corti D; Beck-Peccoz P
    J Endocrinol Invest; 2001 Jun; 24(6):454-9. PubMed ID: 11434671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
    Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
    Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excessively high prolactin level in a patient with a nonprolactin-secreting adenoma. Case report.
    Albuquerque FC; Hinton DR; Weiss MH
    J Neurosurg; 1998 Dec; 89(6):1043-6. PubMed ID: 9833836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab.
    Caponnetto S; Iannantuono GM; Barchiesi G; Magri V; Gelibter A; Cortesi E
    Oncology; 2017; 93(1):62-66. PubMed ID: 28407622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The macroprolactinemia problem and its solution.
    Fahie-Wilson M
    South Med J; 2006 Nov; 99(11):1206. PubMed ID: 17195412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.